Acute treatment with relaxin protects the kidney against ischaemia/reperfusion injury

Although recent preclinical and clinical studies have demonstrated that recombinant human relaxin (rhRLX) may have important therapeutic potential in acute heart failure and chronic kidney diseases, the effects of acute rhRLX administration against renal ischaemia/reperfusion (I/R) injury have never...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Collino, Massimo, Rogazzo, Mara, Pini, Alessandro, Benetti, Elisa, Rosa, Arianna Carolina, Chiazza, Fausto, Fantozzi, Roberto, Bani, Daniele, Masini, Emanuela
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons 2013
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4117562/
https://ncbi.nlm.nih.gov/pubmed/24079335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.12120
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller